![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune to Open New Laboratories and Offices at 1551 Eastlake Ave.
January 18, 2012 09:30 ET
|
TapImmune Inc.
SEATTLE, Jan. 18, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has signed a sub-lease for newly-renovated, state of the art laboratory and office space at 1551 Eastlake Avenue in South Lake...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Appoints Mark Reddish to Its Management Team as Vice President Product Development
November 22, 2011 09:30 ET
|
TapImmune Inc.
SEATTLE, Nov. 22, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), is pleased to announce that Mark Reddish has joined its Management Team as Vice President of Product Development. Mark was...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Inc. to Collaborate With Nature Immunology and Arkitek Studios
November 02, 2011 09:35 ET
|
TapImmune Inc.
SEATTLE, Nov. 2, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce a collaboration with Nature Immunology and Arkitek Studios to visualize TAP's role in combating...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Inc. and Aeras Start Research & Development Collaboration
October 31, 2011 09:25 ET
|
TapImmune Inc.
SEATTLE, Oct. 31, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed a Research Collaboration with Aeras. The overall goal of this collaboration will be to evaluate the...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Inc. Announces Issuance of US Patent
October 27, 2011 09:35 ET
|
TapImmune Inc.
SEATTLE, Oct. 27, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that the US Patent Office has issued Patent 7,994,146 entitled "Method of Enhancing an Immune Response".
The...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune to Present at BIT's 2nd Annual World Congress on Immunodiseases and Therapy in Guangzhou, China, November 18, 2011
October 21, 2011 16:00 ET
|
TapImmune Inc.
SEATTLE, Oct. 21, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company developing immunotherapies, today announced that its Chairman and CEO, Dr. Glynn Wilson, is an invited...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application
August 11, 2011 16:19 ET
|
TapImmune Inc.
SEATTLE and ROCHESTER, Minn., Aug. 11, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a leading biotechnology company developing immunotherapies, today announced that following FDA IND...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Inc to Present at Aegis Capital Emerging Growth Conference in Las Vegas on April 30, 2011
April 28, 2011 09:45 ET
|
TapImmune Inc.
SEATTLE, April 28, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutics and vaccines in the areas of oncology and...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Receives Notice of Allowance for U.S. Patent Application Relating to Vaccines Containing TAP for the Treatment of Pox Virus Infections
April 07, 2011 10:42 ET
|
TapImmune Inc.
SEATTLE, April 7, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Provides Corporate Update
April 05, 2011 09:20 ET
|
TapImmune Inc.
SEATTLE, April 5, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), is pleased to provide this corporate update to our current and future shareholders and other interested parties.
Our...